340B Contract Pharmacy Bills Introduced in Utah, Kansas, New York; Committees Approve Bills in Oregon, Oklahoma

Utah state Sen. Evan Vickers (R), senate majority leader, this week introduced one of multiple new state 340B contract pharmacy bills.
The majority leader of the Utah state senate and a key committee in the Kansas state senate each introduced bills [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amid Double Digit 2023 Growth in 340B, NACHC Urges Federal Over State Reform

Vacheria Keys, director of regulatory affairs at NACHC, said the organization was focused on comprehensive federal 340B reform.
Unreleased figures show “double digit growth again for the 340B program” in 2023, the leader of the 340B prime vendor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Reflecting on Winter Coalition 2024

SPONSORED CONTENT

Last week, the 340B community gathered in the sun-soaked city of San Diego to gain insights, exchange best practices, and navigate the evolving complexities surrounding the program. Whether you missed the 340B Coalition winter event altogether or are seeking a recap to share with your team, this article aims to highlight the pivotal

Read More »

AIDS Group Protests Health Center-Drug Industry Alliance Outside NACHC Policy Forum

AHF protested NACHC's partnership with drug industry advocates outside of a health center policy forum in Washington, D.C.
The AIDS Healthcare Foundation (AHF) staged a protest over the partnership between health centers and drug industry advocates outside a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health System, Drugmakers Battle Over Dismissal Request in 340B Penny Pricing Fraud Suit

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.
A California health system and four drugmakers have filed dueling arguments over the pharmaceutical companies’ effort to dismiss a fraud [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

FTC, HHS Seek Comments on Role of GPOs, Wholesalers on Generic Drug Shortages

Federal Trade Commission sign over entrance.
The FTC and HHS asked for stakeholder feedback on generic drug shortages, which could have implications for the 340B program.
The Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) are requesting comments on how group [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Washington Post Advertorial Highlights Data Critical of 340B Program

A pharmaceutical industry advertorial in the Washington Post questioned whether the 340B program benefited hospital patients.
The leading advocacy group for pharmaceutical manufacturers recently published an advertorial in the Washington Post that highlights a range of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Citing U.S. Supreme Court Decision, Health System Sues Medicare Advantage Plan for Past 340B Payments

An Alabama health system is suing Humana over past reduced 340B rates paid by its Medicare Advantage plans.
Baptist Health of Alabama sued Humana in federal court over the lack of repayment by the company’s Medicare Advantage (MA) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Republican Heavyweights Enter Race to Lead House Committee that Oversees 340B

Rep. Brett Guthrie (R-Ky.) will run to chair the House E&C Committee next session--and is considered by some lobbyists as the favorite to win--if Republicans maintain control of the House.
If House Republicans maintain control of the chamber after the November elections, several senior members will likely vie to chair [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

For Covered Entities, Integrated Care is No Longer an Option

SPONSORED CONTENT

While health leaders have touted the “whole health” approach of integrated healthcare for decades as a way to provide patients with better, more cost-effective care, the COVID-19 pandemic significantly accelerated the adoption and implementation of this model by prompting rapid expansions in telehealth and highlighting

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report